Relationship between universal health insurance benefits and prostate cancer mortality in Colombia.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
30 Sep 2024
Historique:
received: 14 04 2024
accepted: 17 09 2024
medline: 1 10 2024
pubmed: 1 10 2024
entrez: 30 9 2024
Statut: epublish

Résumé

Prostate cancer is the most common cause for cancer mortality among men in Colombia. Law 100, in 1993, created a contributory regime (private insurance) and subsidized regime (public insurance) in which the subsidized regime had fewer benefits. However, Ruling T760 in July 2012 mandated that both systems must offer equal quality and access to healthcare. This study examines the impact of this change on prostate cancer mortality rates before and after 2012. Prostate cancer mortality records from 2006 to 2020 were collected from Colombia's National Administrative Department of Statistics (DANE). Crude mortality was calculated by health insurance for different geographic areas and analyzed for changes between 2006 and 2012 and 2013-2020. Join-Point regressions were used to analyze trends by health insurance. Crude mortality rates in the contributory regime had a non-statistically significant decrease from 2006 to 2012 (AAPC= -1.32%, P = 0.14, 95% CI= -3.12, 0.52). In contrast, between 2013 and 2020 there was a non-statistically significant increase in crude mortality (AAPC 1.10%, P = 0.07, 95% CI= -0.09, 2.31). Comparatively, crude mortality in the subsidized regime, from 2006 to 2012, increased with a statistically significant AAPC of 2.51% (P < 0.001, 95% CI = 1.21, 3.83). From 2013 to 2020, mortality continued to increase with statistically significant AAPC of 5.52% (P < 0.001, 95% CI = 4.77, 6.27). Compared to their crude mortality differences from 2006 to 2020, from 2013 to 2020, the departments of Atlántico, Córdoba, Sucre, Arauca, Cesar, and Cauca had the highest rates in prostate cancer mortality in the subsidized regime compared to the contributory regime. Ruling T760 did not positively impact prostate cancer mortality, particularly of men in the subsidized regime.

Identifiants

pubmed: 39350101
doi: 10.1186/s12889-024-20117-4
pii: 10.1186/s12889-024-20117-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2667

Subventions

Organisme : National Cancer Institute, United States
ID : R25CA112383

Informations de copyright

© 2024. The Author(s).

Références

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Cancer, et al. J Clin. 2021;71(3):209–49.
Wang L, Lu B, He M, Wang Y, Wang Z, Du L. Prostate Cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019. Front Public Health. 2022;10:811044.
doi: 10.3389/fpubh.2022.811044 pubmed: 35252092 pmcid: 8888523
Abila DB, Wasukira SB, Ainembabazi P, Kisuza RK, Nakiyingi EK, Mustafa A, et al. Socioeconomic inequalities in prostate cancer screening in low- and middle-income countries: an analysis of the demographic and health surveys between 2010 and 2019. J Cancer Policy. 2022;34:100360.
doi: 10.1016/j.jcpo.2022.100360 pubmed: 36089226
Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M et al. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer [Internet]. 2020; https://gco.iarc.fr/today
Zhai Z, Zheng Y, Li N, Deng Y, Zhou L, Tian T, et al. Incidence and disease burden of prostate cancer from 1990 to 2017: results from the global burden of Disease Study 2017. Cancer. 2020;126(9):1969–78.
doi: 10.1002/cncr.32733 pubmed: 32012233
Murillo R, Ojeda K, Solano J, Herrera MV, Sánchez O. The Colombian medical oncologists workforce. JGO. 2019;5:1–4.
doi: 10.1200/JGO.19.00221 pubmed: 31657979
Houghton N, Bascolo E, Riego AD. Socioeconomic inequalities in access barriers to seeking health services in four latin American countries. Revista Panam De Salud Pública. 2020;44:1.
de Salud CM, El Consejo Nacional de Seguridad Social en Salud. Ley 100 por el cual se incoporan los servidores publicos al Sistema General de Pensiones y se dictan otras dispociones.Decreto 691 de 1994. 1994.
Gilardino RE, Valanzasca P, Rifkin SB. Has Latin America achieved universal health coverage yet? Lessons from four countries. Archives Public Health. 2022;80(1):38.
doi: 10.1186/s13690-022-00793-7
Colombia. Ministerio de Salud. T-760 por los problemas de regulación como de las facetas pertinentes del derecho a la salud. Sentencia N° T-760 de 2008. 2008.
Lecompte-Osorio P, Lázaro A, Benedetti I. Presentación clínico-patológica Del adenocarcinoma prostático en un Hospital de tercer nivel en Colombia. Revista Urología Colombiana / Colombian Urol J. 2019;29(03):115–22.
Martínez Gómez CL, Flórez CE, González Uribe C, Sánchez Lara M, Vargas Trujillo E, Ruiz Buitrago IC et al. Encuesta Nacional de Demografía y Salud 2015 [Internet]. Bogotá, Colombia: Encuesta Nacional de Demografía y Salud; 2015 p. 834. https://profamilia.org.co/wp-content/uploads/2019/06/Resumen-Ejecutivo-Encuesta-Nacional-De-Demografia-Y-Salud-ends-2015.pdf
Pardo C, de Vries E, Buitrago L, Gamboa Ó. Atlas de mortalidad por cáncer en Colombia [Internet]. Bogotá, Colombia: Intituto Nacional de Cancerología; p. 120. https://www.ins.gov.co/TyS/programas-de-calidad/Documentos%20Programa%20EEDDCARIO/ATLAS_de_Mortalidad_por_cancer_en_Colombia.pdf
De Vries E, Uribe C, Pardo C, Lemmens V, Van De Poel E, Forman D. Gastric cancer survival and affiliation to health insurance in a middle-income setting. Cancer Epidemiol. 2015;39(1):91–6.
doi: 10.1016/j.canep.2014.10.012 pubmed: 25652310
Chayo I, Uribe Perez CJ, De Vries E, Pinheiro PS. The impact of health insurance affiliation and socioeconomic status on cervical cancer survival in Bucaramanga, Colombia. Cancer Epidemiol. 2023;85:102375.
doi: 10.1016/j.canep.2023.102375 pubmed: 37150101
Aday LA, Andersen R. A Framework for the study of Access to Medical Care. Health Serv Res. 1974;9(3):208–20.
pubmed: 4436074 pmcid: 1071804
DANE - General [Internet]. [cited 2023 Jul 19]. https://www.dane.gov.co/index.php/acerca-del-dane/informacion-institucional/generalidades
Salud. [Internet]. [cited 2023 Jul 19]. https://microdatos.dane.gov.co/index.php/catalog/SAL-Microdatos
Gillis D, Edwards BPM. The utility of joinpoint regression for estimating population parameters given changes in population structure. Heliyon. 2019;5(11):e02515.
doi: 10.1016/j.heliyon.2019.e02515 pubmed: 31768426 pmcid: 6872810
Joinpoint Regression Program [Internet]. [cited 2024 May 23]. https://surveillance.cancer.gov/joinpoint/
Downloading IBMSPSS. Statistics 28.0.1.0 [Internet]. 2021 [cited 2023 Sep 16]. https://www.ibm.com/support/pages/downloading-ibm-spss-statistics-28010
Excel. (2016) [Internet]. Microsoft Corporation; https://www.microsoft.com/en-us/microsoft-365/excel?legRedir=true&CorrelationId=f5eba4c0-bb88-4182-99e7-15f083618c73
Download Joinpoint Desktop Software [Internet]. [cited 2023 Jul 26]. https://surveillance.cancer.gov/joinpoint/download
Download QGIS. [Internet]. [cited 2023 Jul 26]. https://www.qgis.org/en/site/forusers/download.html
Garcia-Ramirez J, Nikoloski Z, Mossialos E. Inequality in healthcare use among older people in Colombia. Int J Equity Health. 2020;19(1):168.
doi: 10.1186/s12939-020-01241-0 pubmed: 33100214 pmcid: 7646194
Caicedo-Velásquez B, Restrepo-Méndez MC. The role of individual, household, and area of residence factors on self-rated health in Colombian adults: a multilevel study. Biomedica. 2020;40(2):296–308.
doi: 10.7705/biomedica.4818 pubmed: 32673458 pmcid: 7505506
Higuita-Gutiérrez LF, Estrada-Mesa DA, Cardona-Arias JA. Healthcare inequities experienced by patients with Cancer: a qualitative study in Medellín, Colombia. PPA. 2022;16:1983–97.
doi: 10.2147/PPA.S369628 pubmed: 35958886 pmcid: 9362511
De Vries E, Buitrago G, Quitian H, Wiesner C, Castillo JS. Access to cancer care in Colombia, a middle-income country with universal health coverage. J Cancer Policy. 2018;15:104–12.
doi: 10.1016/j.jcpo.2018.01.003
Borda M, David-Pardo D, Ríos-Zuluaga J, López-Zea A, Forero-Borda L, Gutiérrez S, et al. Asociación entre tamización de cáncer de próstata, vinculación al sistema de salud y factores asociados en adultos mayores: análisis secundario de la encuesta SABE Bogotá, Colombia. Urol Colomb. 2018;27(01):035–41.
doi: 10.1016/j.uroco.2017.02.005
de Vries E, Arroyave I, Pardo C. Time trends in educational inequalities in cancer mortality in Colombia, 1998–2012. BMJ Open. 2016;6(4):e008985.
doi: 10.1136/bmjopen-2015-008985 pubmed: 27048630 pmcid: 4823465
Sanderson M, Coker AL, Perez A, Du XL, Peltz G, Fadden M. K. A multilevel analysis of socioeconomic status and prostate Cancer risk. Ann Epidemiol. 2006;16(12):901–7.
doi: 10.1016/j.annepidem.2006.02.006 pubmed: 16843007 pmcid: 5508518
Simbaña-Rivera K, Torres-Roman JS, Challapa-Mamani MR, Guerrero J, De La Cruz-Ku G, Ybaseta-Medina J, et al. Regional disparities of prostate cancer mortality in Ecuador: an examination of trends and correlates from 2004 to 2019. BMC Public Health. 2023;23(1):992.
doi: 10.1186/s12889-023-15941-z pubmed: 37248460 pmcid: 10226193
Gardner U, McClelland S, Deville C. Disparities in the utilization of Radiation Therapy for prostate Cancer in the United States: a Comprehensive Review. Adv Radiation Oncol. 2022;7(4):100943.
doi: 10.1016/j.adro.2022.100943
Ortiz ZAM, Santamaría FB, Tobar RV, SITUACIÓN ACTUAL DE LA, MUJER EN UROLOGÍA EN COLOMBIA. Arch Españoles De Urología. 2021;74(2):187–96.
Caicedo-Martinez M, Li B, Gonzalez-Motta A, Gamboa O, Bobadilla I, Wiesner C, et al. Radiation Oncology in Colombia: an opportunity for improvement in the Postconflict era. Int J Radiation Oncology*Biology*Physics. 2021;109(5):1142–50.
doi: 10.1016/j.ijrobp.2020.12.006
Castillo-Salgado C. Health Situation Analysis in the Americas, 1999–2000. Epidemiol Bull Pan Am Health Organ. 2000;21.
Viáfara-López CA, Palacios-Quejada G, Banguera-Obregón A. Ethnic-racial inequity in health insurance in Colombia: a cross-sectional study. Revista Panamericana de Salud Pública [Internet]. 2021 [cited 2024 May 24];45. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238259/
Piñeros M, Laversanne M, Barrios E, Cancela MDC, De Vries E, Pardo C, et al. An updated profile of the cancer burden, patterns and trends in Latin America and the Caribbean. Lancet Reg Health - Americas. 2022;13:100294.
doi: 10.1016/j.lana.2022.100294 pubmed: 36189115
dos Reis RB, Alías-Melgar A, Martínez-Cornelio A, Neciosup SP, Sade JP, Santos M, et al. Prostate Cancer in Latin America: challenges and recommendations. Cancer Control. 2020;27(1):1073274820915720.
doi: 10.1177/1073274820915720 pubmed: 32316767 pmcid: 7177984
Khandwala YS, Ohanian A, Huang FW. Prostate Cancer in the Caribbean: A Baseline Assessment of Current practices and potential needs. Cancer Control. 2022;29:10732748221082372.
doi: 10.1177/10732748221082372 pmcid: 8961354
Lillard JW, Moses KA, Mahal BA, George DJ. Racial disparities in black men with prostate cancer: a literature review. Cancer. 2022;128(21):3787–95.
doi: 10.1002/cncr.34433 pubmed: 36066378
lamprea E, García J. Closing the gap between formal and Material Health Care Coverage in Colombia. Health Hum Rights. 2016;18(2):49–65.
pubmed: 28559676 pmcid: 5394995
Así Vamos en Salud. - indicadores en salud normatividad derechos [Internet]. [cited 2024 May 23]. Aseguramiento. https://www.asivamosensalud.org/indicadores/aseguramiento/aseguramiento-georeferenciado
Roncancio DJ, Cutter SL, Nardocci AC. Social vulnerability in Colombia. Int J Disaster Risk Reduct. 2020;50:101872.
doi: 10.1016/j.ijdrr.2020.101872
Peiró-Palomino J, Prieto-Bustos WO, Tortosa-Ausina E. Regional income convergence in Colombia: population, space, and long-run dynamics. Ann Reg Sci. 2023;70(2):559–601.
doi: 10.1007/s00168-022-01163-5 pubmed: 35971341
Garcia Corrales LM, Avila H, Gutierrez RR. Land-use and socioeconomic changes related to armed conflicts: a Colombian regional case study. Environ Sci Policy. 2019;97:116–24.
doi: 10.1016/j.envsci.2019.04.012
Duque JC, García GA, Lozano-Gracia N, Quiñones M, Montoya KY. Inequality and space in a highly unequal country: What does the literature tell us in the context of Colombia? Region Sci Policy Practice. 2023;rsp3.12681.
James ND, Tannock I, N’Dow J, Feng F, Gillessen S, Ali SA, et al. The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet. 2024;403(10437):1683–722.
doi: 10.1016/S0140-6736(24)00651-2 pubmed: 38583453
Roberts R, Mitchell C, Tancawan AL, Pedican M, Jones GW. The prostate cancer screening clinic in the Bahamas: a model for low- and middle-income countries. Cancer Causes Control. 2017;28(11):1187–93.
doi: 10.1007/s10552-017-0972-1 pubmed: 29119339
Oliveira RARD, Guimarães GC, Mourão TC, Favaretto RDL, Santana TBM, Lopes A, et al. Prostate Cancer Screening in Brazil: a single center experience in the public health system. Int braz j urol. 2021;47(3):558–65.
doi: 10.1590/s1677-5538.ibju.2020.0392 pubmed: 33621004
Schröder Fritz H, Jonas H, Roobol Monique J, Tammela Teuvo LJ, Stefano C, Vera N, et al. Screening and prostate-Cancer mortality in a randomized European study. N Engl J Med. 2009;360(13):1320–8.
doi: 10.1056/NEJMoa0810084 pubmed: 19297566
Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, Church TR, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360(13):1310–9.
doi: 10.1056/NEJMoa0810696 pubmed: 19297565 pmcid: 2944770
Hugosson J, Roobol MJ, Månsson M, Tammela TLJ, Zappa M, Nelen V, et al. A 16-yr follow-up of the European randomized study of screening for prostate Cancer. Eur Urol. 2019;76(1):43–51.
doi: 10.1016/j.eururo.2019.02.009 pubmed: 30824296 pmcid: 7513694
Bassett IV, Govindasamy D, Erlwanger AS, Hyle EP, Kranzer K, Van Schaik N, et al. Mobile HIV Screening in Cape Town, South Africa: clinical impact, cost and Cost-Effectiveness. Kumar A. Editor PLoS ONE. 2014;9(1):e85197.
doi: 10.1371/journal.pone.0085197
The Man Van. Mobile targeted case finding for prostate cancer. | Journal of Clinical Oncology [Internet]. [cited 2024 Jul 1]. https://ascopubs.org/doi/abs/ https://doi.org/10.1200/JCO.2023.41.16_suppl.6522
Negoita S, Feuer EJ, Mariotto A, Cronin KA, Petkov VI, Hussey SK, et al. Annual Report to the Nation on the Status of Cancer, part II: recent changes in prostate cancer trends and disease characteristics. Cancer. 2018;124(13):2801–14.
doi: 10.1002/cncr.31549 pubmed: 29786851

Auteurs

Emanuel Mejia (E)

Department of Epidemiology and Biostatistics, CUNY Graduate School of Public Health and Health Policy, New York, NY, USA.

Almira G C Lewis (AGC)

Department of Global Health, School of Public Health, Boston University, Boston, MA, USA.

Isabel C Garcés-Palacio (IC)

Epidemiology group, School of Public Health, Universidad de Antioquia UdeA, Calle 70 No. 52-21, Medellín, Colombia. icristina.garces@udea.edu.co.

Diana M Hernandez (DM)

Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, NY, USA.

Robert M Chamberlain (RM)

Department of Community Health and Social Medicine, City University of New York School of Medicine, New York, NY, USA.

Amr S Soliman (AS)

Department of Community Health and Social Medicine, City University of New York School of Medicine, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH